These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32186248)

  • 21. Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations.
    Katari SK; Natarajan P; Swargam S; Kanipakam H; Pasala C; Umamaheswari A
    J Recept Signal Transduct Res; 2016 Dec; 36(6):558-571. PubMed ID: 26906522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular dynamics guided insight, binding free energy calculations and pharmacophore-based virtual screening for the identification of potential VEGFR2 inhibitors.
    Rathi E; Kumar A; Kini SG
    J Recept Signal Transduct Res; 2019; 39(5-6):415-433. PubMed ID: 31755336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of novel PARP-1 inhibitors using tandem
    Bhatnagar A; Nath V; Kumar N; Kumar V
    J Biomol Struct Dyn; 2024 Apr; 42(7):3396-3409. PubMed ID: 37216358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinformatics and computational studies of chabamide F and chabamide G for breast cancer and their probable mechanisms of action.
    Ray P; Sarker DK; Uddin SJ
    Sci Rep; 2024 Aug; 14(1):19893. PubMed ID: 39191884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring Radioiodinated Anastrozole and Epirubicin as AKT1-Targeted Radiopharmaceuticals in Breast Cancer: In Silico Analysis and Potential Therapeutic Effect with Functional Nuclear Imagining Implications.
    Binmujlli MA
    Molecules; 2024 Sep; 29(17):. PubMed ID: 39275052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring novel and potent molecules for disrupting DEPTOR-mTOR interaction through structure-steered screening, extra-exactitude molecular docking, prime binding free energy estimation and voguish molecular dynamics.
    Shah BA; Ganai SA; Koul AM; Mohan S; Amin A; Wani Z; Majeed U; Rajamanikandan S; Farooq F; Malik FA; Shah NN; Qadri RA
    J Biomol Struct Dyn; 2022; 40(22):12037-12047. PubMed ID: 34431457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
    Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
    J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based virtual screening, pharmacokinetic prediction, molecular dynamics studies for the identification of novel EGFR inhibitors in breast cancer.
    Anbuselvam M; Easwaran M; Meyyazhagan A; Anbuselvam J; Bhotla HK; Sivasubramanian M; Annadurai Y; Kaul T; Pappusamy M; Balasubramanian B
    J Biomol Struct Dyn; 2021 Aug; 39(12):4462-4471. PubMed ID: 32567493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico assessment of new progesterone receptor inhibitors using molecular dynamics: a new insight into breast cancer treatment.
    Zarezade V; Abolghasemi M; Rahim F; Veisi A; Behbahani M
    J Mol Model; 2018 Nov; 24(12):337. PubMed ID: 30415281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput virtual screening of novel potent inhibitor(s) for Human Vanin-1 enzyme.
    Gurung AB; Bhutia JT; Bhattacharjee A
    J Biomol Struct Dyn; 2022 Jun; 40(9):4208-4223. PubMed ID: 33289461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting p53-MDM2 interactions to identify small molecule inhibitors for cancer therapy: beyond "Failure to rescue".
    Chukwuemeka PO; Umar HI; Iwaloye O; Oretade OM; Olowosoke CB; Elabiyi MO; Igbe FO; Oretade OJ; Eigbe JO; Adeojo FJ
    J Biomol Struct Dyn; 2022; 40(19):9158-9176. PubMed ID: 33988074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel flavonoid inhibitor of Catechol-O-Methyltransferase enzyme by molecular screening, quantum mechanics/molecular mechanics and molecular dynamics simulations.
    Govindasamy H; Magudeeswaran S; Poomani K
    J Biomol Struct Dyn; 2020 Nov; 38(18):5307-5319. PubMed ID: 31779524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the suitability of RNA intervention mechanism exerted by some flavonoid molecules against dengue virus MTase RNA capping site: a molecular docking, molecular dynamics simulation, and binding free energy study.
    Manjula S; Kumaradhas P
    J Biomol Struct Dyn; 2020 Aug; 38(12):3533-3543. PubMed ID: 31514688
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Muthiah I; Rajendran K; Dhanaraj P; Vallinayagam S
    J Biomol Struct Dyn; 2021 Aug; 39(13):4807-4815. PubMed ID: 32580684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of HER2 inhibitors from curcumin derivatives using combination of
    Saibu OA; Singh G; Olugbodi SA; Oluwafemi AT; Ajayi TM; Hammed SO; Oladipo OO; Odunitan TT; Omoboyowa DA
    J Biomol Struct Dyn; 2023; 41(21):12328-12337. PubMed ID: 36752338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of plant-based hexokinase 2 inhibitors: combined molecular docking and dynamics simulation studies.
    Khan A; Mohammad T; Shamsi A; Hussain A; Alajmi MF; Husain SA; Iqbal MA; Hassan MI
    J Biomol Struct Dyn; 2022; 40(20):10319-10331. PubMed ID: 34176437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential inhibitors for FKBP51: an
    Barge S; Jade D; Ayyamperumal S; Manna P; Borah J; Nanjan CMJ; Nanjan MJ; Talukdar NC
    J Biomol Struct Dyn; 2022; 40(24):13799-13811. PubMed ID: 34709133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel AChE and BChE inhibitors using combined virtual screening, text mining and in vitro binding assays.
    Sahin K; Zengin Kurt B; Sonmez F; Durdagi S
    J Biomol Struct Dyn; 2020 Jul; 38(11):3342-3358. PubMed ID: 31462153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.